Home Biosimilar Antibodies Immunology & Inflammation CD markers antibody Inotuzumab (Anti-Siglec-2 / CD22) For research use only.
Not for use in humans.

Inotuzumab (Anti-Siglec-2 / CD22)

Synonyms: Humanized Anti-CD22 Recombinant Antibody

Inotuzumab (Anti-Siglec-2 / CD22) is a humanized IgG4, κ monoclonal antibody that targets CD22. Inotuzumab can be used for the research of acute lymphoblastic leukaemia and non-Hodgkin lymphoma. MW : 144.78 kD.

Inotuzumab (Anti-Siglec-2 / CD22)

Purity & Quality Control

Batch: A235801 Purity: 99% Protein concentration: 6.7mg/ml Endotoxin Level: ＜1EU/mg
99

Choose Selective CD markers Inhibitors

Biological Activity

Description Inotuzumab (Anti-Siglec-2 / CD22) is a humanized IgG4, κ monoclonal antibody that targets CD22. Inotuzumab can be used for the research of acute lymphoblastic leukaemia and non-Hodgkin lymphoma. MW : 144.78 kD.

Product Details

CAS No. 1660159-36-3
Molecular Weight 144.78 kDa
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Inotuzumab (Anti-Siglec-2 / CD22) | Inotuzumab (Anti-Siglec-2 / CD22) supplier | purchase Inotuzumab (Anti-Siglec-2 / CD22) | Inotuzumab (Anti-Siglec-2 / CD22) cost | Inotuzumab (Anti-Siglec-2 / CD22) manufacturer | order Inotuzumab (Anti-Siglec-2 / CD22) | Inotuzumab (Anti-Siglec-2 / CD22) distributor